Lv1
26 积分 2025-03-31 加入
Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab
2个月前
已完结
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study
2个月前
已完结
Humoral determinants of checkpoint immunotherapy
4个月前
已完结
The dual role of IL-2 in systemic lupus erythematosus: balancing pro-inflammatory and anti-inflammatory effects
6个月前
已完结
The Lasting Impact of IL-2: Approaching 50 Years of Advancing Immune Tolerance, Cancer Immunotherapies, and Autoimmune Diseases
6个月前
已完结
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
7个月前
已完结
An agonist TIGIT mab suppresses regulatory T cell activity via an IL-2-mediated mechanism
8个月前
已关闭
CAR T-cell therapy in autoimmune diseases
9个月前
已完结
Cell-Selective Targeting Chimeras (SelecTACB) for Membrane Protein Degradation on B Cells
9个月前
已完结
Role of ADAM10/17-mediated Cleavage of LAG3 in the Impairment of Immunosuppression in Psoriasis
10个月前
已完结
皖公网安备34019202002308
